Activation of small-conductance calcium (Ca 2+ )-dependent potassium (K Ca 2) channels (herein called "SK") produces membrane hyperpolarization to regulate membrane excitability. Three subtypes (SK1-3) have been cloned and are distributed throughout the nervous system, smooth muscle, and heart. It is difficult to discern the physiological role of individual channel subtypes as most blockers or enhancers do not discriminate between subtypes. The archetypical blocker apamin displays some selectivity between SK channel subtypes, with SK2 being the most sensitive, followed by SK3 and then SK1. Sensitivity of SK1 is species specific, with the human isoform being blocked by the toxin, whereas the rat is not. Mutation studies have identified residues within the outer pore that suggest apamin blocks by an allosteric mechanism. Apamin also uses a residue within the S3-S4 extracellular loop to produce a high-sensitivity block. We have identified that a 3-amino acid motif within this loop regulates the shape of the channel pore. This motif is required for binding and block by apamin, suggesting that a change in pore shape underlies allosteric block. This motif is absent in rat SK1, explaining why it is insensitive to block by apamin. The overlapping distribution of SK channel subtype expression suggests that native heteromeric channels may be common. We show that the S3-S4 loop of one subunit overlaps the outer pore of the adjacent subunit, with apamin interacting with both regions. This arrangement provides a unique binding site for each combination of SK subunits within a coassembled channel that may be targeted to produce blockers specific for heteromeric SK channels.patch clamp | afterhyperpolarization P harmacological modulation of small-conductance Ca 2+ -activated potassium (SK/K Ca 2) channels has been suggested as a potential target for a number of disorders including dementia, depression, and cardiac arrhythmias. Three subtypes of SK channel have been cloned, with distinct but partially overlapping expression patterns (1-3). A nonpeptidic subtype-specific blocker of SK channels has yet to be developed. The lack of SK subtype selective blockers combined with this wide distribution means that their roles cannot be well defined. This lack of specificity also means that current available SK blockers have a very narrow therapeutic window, with an overlap of doses required for therapeutic benefit and those producing toxic effects in animal studies (4). SK channels are blocked by the bee venom toxin apamin, which displays weak subtype selectivity. The toxin is most potent at SK2 (IC 50 ∼ 70 pM) (5-9) and SK3 (IC 50 ∼ 0.63-6 nM) (7, 9, 10), followed by the human isoform of SK1 (IC 50 ∼ 1-8 nM) (8, 9), whereas the rat isoform of SK1 is apamin insensitive (11,12). Mutation studies have identified a number of residues within the outer pore that affect block by apamin (7,8,13). For example, an outer pore histidine residue has been shown to be critical for both binding and block by the toxin (7). Structural modeling has place...